Acanthamoeba spp. un agente oportunista en infecciones humanas
DOI:
https://doi.org/10.37768/unw.rinv.04.01.002Resumen
Las amebas de vida libre (AVL) se encuentran ampliamente distribuidas en la naturaleza, siendo Acanthamoeba spp. el género más aislado del suelo, aire, aguas tratadas para consumo, agua de mar, lagos y aguas termales. El presente trabajo aborda las características de Acanthamoeba spp., su biología, las patologías que afectan a humanos; además, el diagnóstico microbiológico y molecular, que es una herramienta que ha venido mejorándose con el avance de la tecnología. La clave es la identificación de la ameba, para lograr una buena intervención clínica y terapéutica. Finalmente exponemos las combinaciones terapéuticas exitosas en los escasos reportes clínicos existentes.
Palabras clave: Amebas de vida libre, Acanthamoeba spp., meningoencefalitis, encefalitis granulomatosa amebiana (EGA).
Métricas
Citas
Margulis L. Una revolución en la evolución. Poder para los protoctistas. Pp. 110-111. Colección Honoris Causa. Universitat de València. Valencia, 2003.
Amoebae on the Web. Web-site dedicated to systematics and identification of naked lobose amoebae. Disponible en: <http://amoeba.ifmo.ru/>.
The Amoebae. Disponible en: <http://www.bms.ed.ac.uk/research/others/smaciver/amoebae.htm>.
Martínez AJ. Free-Living Amebas: Natural History, Prevention, Diagnosis, Pathology, and Treatment of Disease. CRC Press, Boca Raton, FL 1985.
Marciano-Cabral F, Cabral G. Acanthamoeba spp. As agents of disease in humans. Clin Microbiol Rev. 2003; 16: 273-307.
Schuster FL, Visvesvara GS. Free-living amoebae as opportunistic and non-opportunistic pathogens of humans and animals. Int J Parasitol. 2004; 34: 1001–1027.
Khan NA. Acanthamoeba: biology and increasing importance in human health. FEMS Microbiol Rev. 2006; 30: 564-595.
Martínez AJ. Free-Living Amebas: Naegleria, Acanthamoeba and Balamuthia In: Baron S, editor. Medical Microbiology. 4th edition. Galveston (TX): University of Texas Medical Branch at Galveston; 1996. Chapter 81.
Khan NA. Acanthamoeba and the bloodbrain barrier: the breakthrough. J Med Microbiol. 2008; 57(Pt 9): 1051-7.
Visvesvara G S. Classification of Acanthamoeba. Rev Infect Dis 1991; 13 Suppl 5: S369-72.
Castellani A. An amoeba found in culture of a year: preliminay note. J Trop Med Hyg. June 2, 1930, p 160; second note: July 1, 1930, p 188; third note: August 1, 1930, p 221.
Douglas M. Notes on the classification of the amoeba found by Castellani on culture of yeast-like fungus. J Trop Med Hyg, 1930; 33: 258-59.
Culbertson CG, Smith JW, Minner JR et al. Acanthamoeba: observations on animal pathogenicity. Science. 1958; 127: 1506.
Jahnes W G, Fulmer H M, Li CP. Free-living amoeba as contaminants in monkey kidney tissue cultures (23515). Proceed Soc Exp Biol Med 1957; 96: 484-8.
Culbertson CG, Smith JW, Cohen HK, Minner JR. Experimental infection of mice and monkeys by Acanthamoeba. Am J Pathol 1959; 35: 185-97.
Page FC. Re-definition of the genus Acanthamoeba with description of three species. J. Protozool. 1967; 14: 709-724.
Visvesvara GS, Maguire JH. Pathogenic and opportunistic free-living amebas: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea. In: RL Guerrant, DH Walker, PF Weller (Eds.), Tropical Infectious Diseases: Principles, Pathogens & Practice. Vol. 2. Churchill Livingstone (Elsevier), Philadelphia, 2006, pp. 1114-1125.
Adl SM, Simpson AGB, Farmer MA, et al. The new higher level classification of eukaryotes with emphasis on the taxonomy of protists. J Eukaryot Microbiol 2005; 52: 399-451.
Visvesvara GS, Roy SL, Maguire JH. Pathogenic and Opportunistic FreeLiving Amebae. Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia pedata. Chapter 101. In: Richard L. Guerrant, David H. Walker, and Peter F. Weller, Edited. Tropical Infectious Diseases: Principles, Pathogens and Practice, 3ed Hardcover. 2011. Pp. 707-713.
Visvesvara GS. Pathogenic and Opportunistic Free-living Amoebae: Agents of Human and Animal Disease. Chapter 50.
Pussard M, Pons R. Morphologies de la paroi kystique et taxonomie du genre Acanthamoeba (Protozoa, Amoebida). Protistologica 1977; 13: 557–610.
Page FC. A New Key to Freshwater and Soil Gymnamoebae. Freshwater Biological Association, Cumbria, 1988. 122 p.
Cerva L, Serbus C, Skocil V. Isolation of limax amoebae from the nasal mucosa of man. Folia Parasitol. (Praha). 1973; 20, 97–103.
Badenoch PR, Grimmond TR, Cadwgan J, Deayton SE, Essery MSL, Hill BD. Nasal Carriage of Free-Living Amoebae. Microbial Ecology in Health and Disease. 1988; 1 (3), 209-211.
Cabello-Vílchez AM, Martín-Navarro CM, López-Arencibia A, Reyes-Batlle M, González AC, Guerra H, Gotuzzo E, Valladares B, Piñero JE, Lorenzo-Morales J. Genotyping of potentially pathogenic Acanthamoeba strains isolated from nasal swabs of healthy individuals in Peru. Acta Trop. 2013; 130C: 7-10.
Dunand VA, Hammer SM, Rossi R, et al. Parasitic sinusitis and otitis in patients infected with human immunodeficiency virus: report of five cases and review. Clin Infect Dis 1997; 25: 267-72.
Dickson JM, Zetler PJ, Walker B, Javer AR. Acanthamoeba rhinosinusitis. J Otolaryngol Head Neck Surg. 2009; 38 (3): E87-90.
Nachega JB, Rombaux P, Weynand B, Thomas G, Zech F. Successful treatment of Acanthamoeba rhinosinusitis in a patient with AIDS. AIDS Patient Care STDS. 2005 Oct; 19 (10): 621-5.
Rivera MA, Padhya TA. Acanthamoeba: a rare primary cause of rhinosinusitis. Laryngoscope 2002; 112: 1201-3.
Teknos TN, Poulin MD, Laruentano AM. Acanthamoeba rhinosinusitis: characterization, diagnosis, and treatment. Am J Rhinol 2001; 14: 387-91.
Kim SY, Syms MJ, Holtel MR, et al. Acanthamoeba sinusitis with subsequent dissemination in an AIDS patient. Ear Nose Throat J 2000; 79: 171-4.
Gonzalez MM, Gould E, Dickinson G, Martinez AJ, Visvesvara G, Cleary TJ, Hensley GT. 1986. Acquired immunodeficiency sindrome associated with Acanthamoeba infection and other opportunistic organisms. Arch. Pathol. Lab. Med. 110: 749–751.
Helton J, Loveless M, White CR Jr. Cutaneous Acanthamoeba infection associated with leukocytoclastic vasculitis in an AID Spatient. Am. J. Dermatopathol. 1993; 15: 146-149.
Murakawa GJ, McCalmont T, Altman J, Telang GM, Hoffman MD, Kantor
GR, Berger TG. Disseminated acanthamebiasis in patients with AIDS. A report of five cases and a review of the literature. Arch. Dermatol. 1995; 131: 1291-1296.
Duluol AM, Teilhac MF, Poirot JL. Cutaneous lesions due to Acanthamoeba sp. in patients with AIDS. J. Eukaryot. Microbiol. 1996; 43: 130-131.
Chandrasekar, PH, Nandi PS, Fairfax MR, Crane LR. Cutaneous infections due to Acanthamoeba in patients with acquired immunodeficiency syndrome. Arch. Intern. Med. 1997; 157: 569-572.
Bonilla, HF, Whitehurst A, Kauffman CA. Acanthamoeba sinusitis and disseminated infection in a patient with AIDS. Infect. Med. 1999; 16: 397-400.
Casper T, Basset D, Leclercq C, Fabre J, Peyron-Raison N, Reynes J. Disseminated acanthamoeba infection in a patient with AIDS: response to 5-fluorocytosine therapy. Clin. Infect. Dis. 1999; 29: 944-945.
Friedland LR, Raphael SA, Deutsch ES, et al. Disseminated Acanthamoeba infection in a child with symptomatic human immunodeficiency virus infection. Pediatr Infect Dis J 1992; 11: 404-407.
Cugino L, Butcher J, Hoppes WL, Doyle M, Bogden C. Acanthamoeba sinusitis in a patient with AIDS. Clin Infect Dis 1995; 21: 795.
Sison JP, Kemper CA, Loveless M, McShane D, Visvesvara GS, Deresinski SC. Disseminated Acanthamoeba infection in patients with AIDS: Case reports and review. Clin Infect Dis 1995; 20: 1207–1216.
Landres B. Acanthamoeba Sinusitis in a Patient with Acquired Immunodeficiency Syndrome. Proceedings of UCLA Healthcare-Summer 2000; 4: (2): 4-7.
Carter WW, Gompf SG, Toney JF, et al. Disseminated Acanthamoeba sinusitis in a patient with AIDS: A posible role for early antiretroviral therapy. AIDS Read 2004; 14: 41-49.
Galarza C, Ramos W, Gutierrez EL, Ronceros G, Teran M, Uribe M, Navincopa M, Ortega-Loayza AG. Cutaneous acanthamebiasis infection in immunocompetent and immunocompromised patients. Int J Dermatol. 2009; 48(12): 1324-9.
Slater CA, Sickel JZ, Visvesvara GS, Pabico RC, Gaspari A. Brief report: successful treatment of disseminated Acanthamoeba infection in an immunocompromised patient. N. Engl. J. Med.1994; 331: 85-87.
Van Hamme C, Dumont M, Delos M, Lachapelle JM. Acanthamibiase cutanee chez un transplante pulmonaire. Ann. Dermatol. Venereol. 2001; 128: 1237-1240.
Panjwani N, Zhao Z, Baum J, Hazlett LD, Yang Z. Acanthamoebae bind to rabbit corneal epithelium in vitro. Invest Ophthalmol Vis Sci 1997; 38: 1858-64.
Siddiqui R, Emes R, Elsheikha H, Khan NA. Area 51: How do Acanthamoeba invade the central nervous system? Trends Parasitol 2011; 27: 185-9.
Garate M, Marchant J, Cubillos I, Cao Z, Khan NA, Panjwani N. In vitro pathogenicity of Acanthamoeba is associated with the expression of the mannose-binding protein. Invest Ophthalmol Vis Sci 2006; 47: 1056-62.
Garate M, Cao Z, Bateman E, Panjwani N. Cloning and characterization of a novel mannose-binding protein of Acanthamoeba. J Biol Chem 2004; 279: 29849-56.
Siddiqui R, Khan NA. Biology and pathogenesis of Acanthamoeba. Parasit Vectors. 2012; 5: 6.
Hong YC, Lee WM, Kong HH, Jeong HJ, Chung DI: Molecular cloning and characterization of a cDNA encoding a laminin-binding protein (AhLBP) from Acanthamoeba healyi. Exp Parasitol 2004, 106: 95-102.
Rocha-Azevedo BD, Jamerson M, Cabral GA, Marciano-Cabral F: Acanthamoeba culbertsoni: Analysis of amoebic adhesion and invasion on extracellular matrix components collagen I and laminin-1. Exp Parasitol 2009, 126: 79-84.
Yang Z, Cao Z, Panjwani N. Pathogenesis of Acanthamoeba keratitis: carbohydrate-mediated host-parasite interactions. Infect Immun. 1997; 65(2): 439-45.
Khan NA, Paget TA. Molecular tools for speciation and epidemiological studies of Acanthamoeba. Curr Microbiol. 2002; 44(6): 444-9.
Khan NA, Jarroll EL, Panjwani N, Cao Z, Paget TA. Proteases as markers for differentiation of pathogenic and nonpathogenic species of Acanthamoeba. J Clin Microbiol. 2000; 38(8): 2858-61.
Alfieri SC, Correia CE, Motegi SA & Pral EM. Proteinase activities in total extracts and in medium conditioned by Acanthamoeba polyphaga trophozoites. J Parasitol 2000; 86: 220–227.
Na BK, Kim JC, Song CY. Characterization and pathogenetic role of proteinase from Acanthamoeba castellanii. Microb Pathog. 2001; 30(1): 39-48.
Alsam S, Sissons J, Jayasekera S, Khan NA. Extracellular proteases of Acanthamoeba castellanii (encephalitis isolate belonging to T1 genotype) contribute to increased permeability in an in vitro model of the human blood–brain barrier. J. Infect. 2005; 51, 150-156.
Sissons J, Alsam S, Goldsworthy G, Lightfoot M, Jarroll EL, Khan NA. Identification and properties of proteases from an Acanthamoeba isolate capable of producing granulomatous encephalitis. BMC Microbiol. 2006; 6, 42.
Serrano-Luna JdeJ, Cervantes-Sandoval I, Calderón J, Navarro-García F, Tsutsumi V, Shibayama M. Protease activities of Acanthamoeba polyphaga and Acanthamoeba castellanii. Can J Microbiol 2006; 52: 16-23.
Dudley R, Alsam S, Khan NA. The role of proteases in the differentiation of Acanthamoeba castellanii. FEMS Microbiol Lett 2008; 286: 9-15.
De Souza Carvalho FR, Carrijo-Carvalho LC, Chudzinski-Tavassi AM, Foronda AS, de Freitas D. Serine-like proteolytic enzymes correlated with differential pathogenicity in patients with acute Acanthamoeba keratitis. Clin Microbiol Infect. 2011; 17 (4): 603-9.
Moon EK, Hong Y, Chung DI, Kong HH. Cysteine protease involving in autophagosomal degradation of mitochondria during encystation of Acanthamoeba. Mol Biochem Parasitol. 2012; 185(2): 121-6.
Hadas E, Mazur T. Proteolytic enzymes of pathogenic and non-pathogenic strains of Acanthamoeba spp. Trop Med Parasitol. 1993; 44(3): 197-200.
Kim HK, Ha YR, Yu HS, Kong HH, Chung DI. Purification and characterization of a 33 kDa serine protease from Acanthamoeba lugdunensis KA/E2 isolated from a Korean keratitis patient. Korean J Parasitol. 2003; 41(4): 189-96.
Ferreira GA, Magliano AC, Pral EM, Alfieri SC. Elastase secretion in Acanthamoeba polyphaga. Acta Trop. 2009; 112(2): 156-63.
Alizadeh H, Li H, Neelam S, Niederkorn JY. Modulation of corneal and stromal matrix metalloproteinase by the mannose-induced Acanthamoeba cytolytic protein. Exp Eye Res. 2008; 87(3): 286-91.
Tripathi T, Alizadeh H. Role of protease-activated receptors 2 (PAR2) in ocular infections and inflammation. Receptors Clin Investig. 2014; 1(6). pii: e2991.
Park MK, Cho MK, Kang SA, Park HK, Kim DH, Yu HS. Acanthamoeba protease activity promotes allergic airway inflammation via proteaseactivated receptor 2. PLoS One. 2014; 21: 9(3) e92726.
Iqbal J, Panjwani S, Siddiqui R, Khan NA. Partial characterization of Acanthamoeba castellanii (T4 genotype) DNase activity. Parasitol Res. 2015; 114(2): 457-63.
Ferrante A. Immunity to Acanthamoeba. Rev Infect Dis 1991; 13: S403-9.
Clarke DW, Niederkorn JY. The pathophysiology of Acanthamoeba keratitis. Trends Parasitol 2006; 22: 175-80.
Alizadeh H, Apte S, El-Agha MS, et al. Tear IgA and serum IgG antibodies against Acanthamoeba in patients with Acanthamoeba keratitis. Cornea 2001; 20: 622-7.
Cerva L. Acanthamoeba culbertsoni and Naegleria fowleri: occurrence of antibodies in man. J Hyg Epidemiol Microbiol Immunol 1989; 33: 99-103.
Kenney M. Micro-Kolmer complement fixation test in routine screening for soil ameba infections. Health Lab Sci 1971; 8: 5-10.
Chappell C, Wright JA, Coletta M, et al. Standardized methods of measuring Acanthamoeba antibodies in sera from healthy human subjects. Clin Diagn Lab Immunol 2001; 8: 724-30.
Visvesvara GS, Moura H, Schuster FL. Pathogenic and opportunistic free-living amebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea. FEMS Immunol Microbiol 2007; 50: 1-26 Review.
Marciano-Cabral F, Cabral G. Acanthamoeba spp. as agents of disease in humans. Clin Microbiol Rev. 2003; 16(2): 273–307. Review.
Cabello-Vílchez AM, Rodríguez-Zaragoza S, Piñero J, Valladares B, Lorenzo-Morales J. Balamuthia mandrillaris in South America: an emerging potential hidden pathogen in Peru. Exp Parasitol. 2014; 145 Suppl: S10-9 Review.
Neff RJ. Purification, axenic cultivation, and description of a soil amoeba. Acanthamoeba sp. J. Protozool. 1957; 4: 176-182.
Page FC. Nackte Rhizopoda. In: Nackte Rhizopoda und Heliozoea (Eds. Page F.C. and Siemensma F.J.). G. Fischer Verlag, Stuttgart-New York, 1991; pp. 1-170.
Pussard M, Pons R. Morphologies de la paroi kystique et taxonomie du genre Acanthamoeba (Protozoa, Amoebida). Protistologica 1977; 13: 557-610.
Schuster FL. Cultivation of pathogenic and opportunistic free-living amebas. Clin Microbiol Rev. 2002; 15(3): 342-54. Review.
Stothard DR, Schroeder-Diedrich JM, Awwad MH, Gast RJ, Ledee DR, Rodriguez-Zaragoza S, Dean CL, Fuerst PA, Byers TJ. The evolutionary history of the genus Acanthamoeba and the identification of eight new 18S rRNA gene sequence types. J. Eukaryot. Microbiol. 1998; 45: 45-54
Nuprasert W, Putaporntip C, Pariyakanok L, Jongwutiwes S. Identification of a novel T17 genotype of Acanthamoeba from environmental isolates and T10 genotype causing keratitis in Thailand. Journal of Clinical Microbiology. 2010; 48: 4636-4640.
Qvarnstrom Y, Nerad TA, Visvesvara GS. Characterization of a new pathogenic Acanthamoeba Species, A. byersi n. sp., isolated from a human with fatal amoebic encephalitis. J Eukaryot Microbiol. 2013; 60 (6): 626-33.
Magnet A, Henriques-Gil N, Galván-Díaz AL, Izquiedo F, Fenoy S, del Aguila C. Novel Acanthamoeba 18S rRNA gene sequence type from an environmental isolate. Parasitol Res. 2014; 113 (8): 2845-50.
Corsaro D, Walochnik J, Köhsler M, Rott MB. Acanthamoeba misidentification and multiple labels: redefining genotypes T16, T19, and T20 and proposal for Acanthamoeba micheli sp. nov. (genotype T19). Parasitol Res. 2015; 114 (7): 2481-90.
Schroeder JM, Booton GC, Hay J, Niszl IA, Seal DV, Markus MB, Fuerst PA, Byers TJ. Use of subgenic 18S ribosomal DNA PCR and sequencing for genus and genotype identification of acanthamoebae from humans with keratitis and from sewage sludge. J Clin Microbiol. 2001; 39 (5): 1903-11.
Booton GC, Kelly DJ, Chu YW, Seal DV, Houang E, Lam DS, Byers TJ, Fuerst PA. 18S ribosomal DNA typing and tracking of Acanthamoeba species isolates from corneal scrape specimens, contact lenses, lens cases, and home water supplies of Acanthamoeba keratitis patients in Hong Kong. J Clin Microbiol. 2002; 40 (5): 1621-5.
Fuerst PA, Booton GC, Visvesvara GS, Byers TJ. Genotypic identification of non-keratitis infections caused by the opportunistically pathogenic ameba genus Acanthamoeba. J Eukaryot Microbiol. 2003; 50 Suppl: 512-3.
Booton GC, Visvesvara GS, Byers TJ, Kelly DJ, Fuerst PA. Identification and distribution of Acanthamoeba species genotypes associated with nonkeratitis infections. J Clin Microbiol. 2005; 43(4): 1689-93.
Yagi S, Schuster FL, Bloch K. Demonstration of presence of Acanthamoeba mitochondrial DNA in brain tissue and cerebrospinal fluid by PCR in samples from a patient who died of granulomatous amebic encephalitis. J Clin Microbiol. 2007; 45 (6): 2090-1.
Walochnik J, Aichelburg A, Assadian O, Steuer A, Visvesvara G, Vetter N, Aspöck H. Granulomatous amoebic encephalitis caused by Acanthamoeba amoebae of genotype T2 in a human immunodeficiency virusnegative patient. J Clin Microbiol. 2008 Jan; 46 (1): 338-40.
Fuerst PA, Booton GC, Visvesvara GS, Byers TJ. Genotypic identification of non-keratitis infections caused by the opportunistically pathogenic ameba genus Acanthamoeba. J Eukaryot Microbiol. 2003; 50 Suppl: 512-3.
Lackner P, Beer R, Broessner G, Helbok R, Pfausler B, Brenneis C, Auer H, Walochnik J, Schmutzhard E. Acute granulomatous acanthamoeba encephalitis in an immunocompetent patient. Neurocrit Care. 2010; 12(1): 91-4.
Köhsler M, Leitner B, Blaschitz M, Michel R, Aspöck H, Walochnik J. ITS1 sequence variabilities correlate with 18S rDNA sequence types in the genus Acanthamoeba (Protozoa: Amoebozoa). Parasitol Res. 2006; 98(2): 86-93.
Lehmann OJ, Green SM, Morlet N, Kilvington S, Keys MF, Matheson MM, Dart JK, McGill JI, Watt PJ. Polymerase chain reaction analysis of corneal epithelial and tear samples in the diagnosis of Acanthamoeba keratitis. Invest Ophthalmol Vis Sci. 1998; 39(7): 1261-5.
Yera H, Zamfir O, Bourcier T, Ancelle T, Batellier L, Dupouy-Camet J, Chaumeil C. Comparison of PCR, microscopic examination and culture forthe early diagnosis andcharacterization of Acanthamoeba isolates from ocular infections. Eur J Clin Microbiol Infect Dis. 2007; 26 (3): 2 21-4.
Yagi S, Schuster FL, Visvesvara GS. Demonstration of Balamuthia and Acanthamoeba mitochondrial DNA in sectioned archival brain and other tissues by the polymerase chain reaction. Parasitol Res. 2008 Feb; 102 (3): 491-7.
Walochnik J, Aichelburg A, Assadian O, Steuer A, Visvesvara G, Vetter N, Aspöck H. Granulomatous amoebic encephalitis caused by Acanthamoeba amoebae of genotype T2 in a human immunodeficiency virusnegative patient. J Clin Microbiol. 2008; 46 (1): 338-40.
Yagi S, Schuster FL, Bloch K. Demonstration of presence of Acanthamoeba mitochondrial DNA in brain tissue and cerebrospinal fluid by PCR in samples from a patient who died of granulomatous amebic encephalitis. J Clin Microbiol. 2007; 45 (6): 2090-1.
Oliva S, Jantz M, Tiernan D, et al. Successful treatment of widely disseminated acanthamebiasis. South Med J 1999; 92: 55-7.
Vernon SE, Acar BC, Pham SM, et al. Acanthamoeba infection in lung transplantation: report of a case and review of the literature. Transpl Infect Dis 2005; 7: 154-7.
Walia R, Montoya JG, Visvesvara GS, et al. A case of successful treatment of cutaneous Acanthamoeba infection in a lung transplant recipient. Transpl Infect Dis 2007; 9: 51-4.
Tang-Tat Fung K, Dhillon AP, McLaughlin JE, et al. Cure of Acanthamoeba cerebral abscess in a liver transplant patient. Liver Transpl 2008; 14: 308-12.
Singhal T, Bajpai A, Kalra V, et al. Successful treatment of Acanthamoeba meningitis with combination of antimicrobials. Pediatr Infect Dis 2001; 20: 623-7.
Petry F, Torzewski M, Bohl J, et al. Early diagnosis of Acanthamoeba infection during routine cytological examination of cerebrospinal fluid. J Clin Microbiol 2006; 44: 1903-4.
Martínez MS, Gonzalez-Mediero G, Santiago P, et al. Granulomatous amebic encephalitis in a patient with AIDS: isolation of Acanthamoeba sp. group II from brain tissue and successful treatment with sulfadiazine and fluconazole. J Clin Microbiol 2000; 38: 3892-5.
Aichelburg AC, Walochnik J, Assadian O, et al. Successful treatment of disseminated Acanthamoeba spp. infection with Miltefosine. Emerg Infect Dis 2008; 141: 743-6.
Cabello-Vílchez AM, Martín-Navarro CM, López-Arencibia A, Reyes-Batlle M, Sifaoui I, Valladares B, Piñero JE, Lorenzo-Morales J. Voriconazole as a first-line treatment against potentially pathogenic Acanthamoeba strains from Peru. Parasitol Res. 2014; 113(2): 755-9.
Martínez DY, Seas C, Bravo F, Legua P, Ramos C, Cabello AM, Gotuzzo E. Successful treatment of Balamuthia mandrillaris amoebic infection with extensive neurological and cutaneous involvement. Clin Infect Dis. 2010; 51(2): e7-11.
